The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide

The neonatal and pediatric antimicrobial point prevalence survey (PPS) of the Antibiotic Resistance and Prescribing in European Children project (http://www.arpecproject.eu/) aims to standardize a method for surveillance of antimicrobial use in children and neonates admitted to the hospital within E...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Pediatric infectious disease journal 2013-06, Vol.32 (6), p.e242-e253
Hauptverfasser: Versporten, Ann, Sharland, Mike, Bielicki, Julia, Drapier, Nico, Vankerckhoven, Vanessa, Goossens, Herman
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e253
container_issue 6
container_start_page e242
container_title The Pediatric infectious disease journal
container_volume 32
creator Versporten, Ann
Sharland, Mike
Bielicki, Julia
Drapier, Nico
Vankerckhoven, Vanessa
Goossens, Herman
description The neonatal and pediatric antimicrobial point prevalence survey (PPS) of the Antibiotic Resistance and Prescribing in European Children project (http://www.arpecproject.eu/) aims to standardize a method for surveillance of antimicrobial use in children and neonates admitted to the hospital within Europe. This article describes the audit criteria used and reports overall country-specific proportions of antimicrobial use. An analytical review presents methodologies on antimicrobial use. A 1-day PPS on antimicrobial use in hospitalized children was organized in September 2011, using a previously validated and standardized method. The survey included all inpatient pediatric and neonatal beds and identified all children receiving an antimicrobial treatment on the day of survey. Mandatory data were age, gender, (birth) weight, underlying diagnosis, antimicrobial agent, dose and indication for treatment. Data were entered through a web-based system for data-entry and reporting, based on the WebPPS program developed for the European Surveillance of Antimicrobial Consumption project. There were 2760 and 1565 pediatric versus 1154 and 589 neonatal inpatients reported among 50 European (n = 14 countries) and 23 non-European hospitals (n = 9 countries), respectively. Overall, antibiotic pediatric and neonatal use was significantly higher in non-European (43.8%; 95% confidence interval [CI]: 41.3-46.3% and 39.4%; 95% CI: 35.5-43.4%) compared with that in European hospitals (35.4; 95% CI: 33.6-37.2% and 21.8%; 95% CI: 19.4-24.2%). Proportions of antibiotic use were highest in hematology/oncology wards (61.3%; 95% CI: 56.2-66.4%) and pediatric intensive care units (55.8%; 95% CI: 50.3-61.3%). An Antibiotic Resistance and Prescribing in European Children standardized web-based method for a 1-day PPS was successfully developed and conducted in 73 hospitals worldwide. It offers a simple, feasible and sustainable way of data collection that can be used globally.
doi_str_mv 10.1097/INF.0b013e318286c612
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1399507649</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1399507649</sourcerecordid><originalsourceid>FETCH-LOGICAL-c171t-53478a10f4136b14f0ee982b8eb88dff7065bf759f8b721446d6e05182ac28eb3</originalsourceid><addsrcrecordid>eNpdUU1P3DAQtSqqsqX9Bwj5yCV0HDu201u1Wlok1F7oObKdSdco6yy2w4q_xK-sowUOnCzPvA-9eYScM7hi0KpvN7-vr8AC48iZrrV0ktUfyIo1vK6g1eqErEC3rOJS6lPyOaV7AOCCwSdyWnPNtRKwIs93W6QmZG_9lL2jEZNP2QS3THu6L38XyzL8oz7QzRynPZpA11s_9hFDAUz36PJ3amjAKZhsxiMRe29yLIqL-M67OFlfdge0lTUJC2LyIS8Gj2bExS_N8RGfFhvF6XZKe1_EEj1McewPvscv5ONQBvj15T0jf683d-tf1e2fnzfrH7eVY4rlquFCacNgEIxLy8QAiK2urUardT8MCmRjB9W0g7aqZkLIXiI05YbG1QXEz8jlUbdke5gx5W7nk8NxNCXhnDrG27YBJUVboOIILfFSijh0--h3Jj51DLqlpa601L1vqdAuXhxmu8P-jfRaC_8PZN2SDw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1399507649</pqid></control><display><type>article</type><title>The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Versporten, Ann ; Sharland, Mike ; Bielicki, Julia ; Drapier, Nico ; Vankerckhoven, Vanessa ; Goossens, Herman</creator><creatorcontrib>Versporten, Ann ; Sharland, Mike ; Bielicki, Julia ; Drapier, Nico ; Vankerckhoven, Vanessa ; Goossens, Herman ; ARPEC Project Group Members</creatorcontrib><description>The neonatal and pediatric antimicrobial point prevalence survey (PPS) of the Antibiotic Resistance and Prescribing in European Children project (http://www.arpecproject.eu/) aims to standardize a method for surveillance of antimicrobial use in children and neonates admitted to the hospital within Europe. This article describes the audit criteria used and reports overall country-specific proportions of antimicrobial use. An analytical review presents methodologies on antimicrobial use. A 1-day PPS on antimicrobial use in hospitalized children was organized in September 2011, using a previously validated and standardized method. The survey included all inpatient pediatric and neonatal beds and identified all children receiving an antimicrobial treatment on the day of survey. Mandatory data were age, gender, (birth) weight, underlying diagnosis, antimicrobial agent, dose and indication for treatment. Data were entered through a web-based system for data-entry and reporting, based on the WebPPS program developed for the European Surveillance of Antimicrobial Consumption project. There were 2760 and 1565 pediatric versus 1154 and 589 neonatal inpatients reported among 50 European (n = 14 countries) and 23 non-European hospitals (n = 9 countries), respectively. Overall, antibiotic pediatric and neonatal use was significantly higher in non-European (43.8%; 95% confidence interval [CI]: 41.3-46.3% and 39.4%; 95% CI: 35.5-43.4%) compared with that in European hospitals (35.4; 95% CI: 33.6-37.2% and 21.8%; 95% CI: 19.4-24.2%). Proportions of antibiotic use were highest in hematology/oncology wards (61.3%; 95% CI: 56.2-66.4%) and pediatric intensive care units (55.8%; 95% CI: 50.3-61.3%). An Antibiotic Resistance and Prescribing in European Children standardized web-based method for a 1-day PPS was successfully developed and conducted in 73 hospitals worldwide. It offers a simple, feasible and sustainable way of data collection that can be used globally.</description><identifier>ISSN: 0891-3668</identifier><identifier>EISSN: 1532-0987</identifier><identifier>DOI: 10.1097/INF.0b013e318286c612</identifier><identifier>PMID: 23838740</identifier><language>eng</language><publisher>United States</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Child ; Drug Prescriptions - statistics &amp; numerical data ; Drug Resistance, Bacterial ; Drug Utilization - statistics &amp; numerical data ; Electronic Data Processing ; Europe ; Health Services Research - methods ; Health Services Research - standards ; Hospitals ; Humans ; Internet ; Public Health Administration - methods ; Public Health Administration - standards</subject><ispartof>The Pediatric infectious disease journal, 2013-06, Vol.32 (6), p.e242-e253</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c171t-53478a10f4136b14f0ee982b8eb88dff7065bf759f8b721446d6e05182ac28eb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23838740$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Versporten, Ann</creatorcontrib><creatorcontrib>Sharland, Mike</creatorcontrib><creatorcontrib>Bielicki, Julia</creatorcontrib><creatorcontrib>Drapier, Nico</creatorcontrib><creatorcontrib>Vankerckhoven, Vanessa</creatorcontrib><creatorcontrib>Goossens, Herman</creatorcontrib><creatorcontrib>ARPEC Project Group Members</creatorcontrib><title>The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide</title><title>The Pediatric infectious disease journal</title><addtitle>Pediatr Infect Dis J</addtitle><description>The neonatal and pediatric antimicrobial point prevalence survey (PPS) of the Antibiotic Resistance and Prescribing in European Children project (http://www.arpecproject.eu/) aims to standardize a method for surveillance of antimicrobial use in children and neonates admitted to the hospital within Europe. This article describes the audit criteria used and reports overall country-specific proportions of antimicrobial use. An analytical review presents methodologies on antimicrobial use. A 1-day PPS on antimicrobial use in hospitalized children was organized in September 2011, using a previously validated and standardized method. The survey included all inpatient pediatric and neonatal beds and identified all children receiving an antimicrobial treatment on the day of survey. Mandatory data were age, gender, (birth) weight, underlying diagnosis, antimicrobial agent, dose and indication for treatment. Data were entered through a web-based system for data-entry and reporting, based on the WebPPS program developed for the European Surveillance of Antimicrobial Consumption project. There were 2760 and 1565 pediatric versus 1154 and 589 neonatal inpatients reported among 50 European (n = 14 countries) and 23 non-European hospitals (n = 9 countries), respectively. Overall, antibiotic pediatric and neonatal use was significantly higher in non-European (43.8%; 95% confidence interval [CI]: 41.3-46.3% and 39.4%; 95% CI: 35.5-43.4%) compared with that in European hospitals (35.4; 95% CI: 33.6-37.2% and 21.8%; 95% CI: 19.4-24.2%). Proportions of antibiotic use were highest in hematology/oncology wards (61.3%; 95% CI: 56.2-66.4%) and pediatric intensive care units (55.8%; 95% CI: 50.3-61.3%). An Antibiotic Resistance and Prescribing in European Children standardized web-based method for a 1-day PPS was successfully developed and conducted in 73 hospitals worldwide. It offers a simple, feasible and sustainable way of data collection that can be used globally.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Child</subject><subject>Drug Prescriptions - statistics &amp; numerical data</subject><subject>Drug Resistance, Bacterial</subject><subject>Drug Utilization - statistics &amp; numerical data</subject><subject>Electronic Data Processing</subject><subject>Europe</subject><subject>Health Services Research - methods</subject><subject>Health Services Research - standards</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Internet</subject><subject>Public Health Administration - methods</subject><subject>Public Health Administration - standards</subject><issn>0891-3668</issn><issn>1532-0987</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdUU1P3DAQtSqqsqX9Bwj5yCV0HDu201u1Wlok1F7oObKdSdco6yy2w4q_xK-sowUOnCzPvA-9eYScM7hi0KpvN7-vr8AC48iZrrV0ktUfyIo1vK6g1eqErEC3rOJS6lPyOaV7AOCCwSdyWnPNtRKwIs93W6QmZG_9lL2jEZNP2QS3THu6L38XyzL8oz7QzRynPZpA11s_9hFDAUz36PJ3amjAKZhsxiMRe29yLIqL-M67OFlfdge0lTUJC2LyIS8Gj2bExS_N8RGfFhvF6XZKe1_EEj1McewPvscv5ONQBvj15T0jf683d-tf1e2fnzfrH7eVY4rlquFCacNgEIxLy8QAiK2urUardT8MCmRjB9W0g7aqZkLIXiI05YbG1QXEz8jlUbdke5gx5W7nk8NxNCXhnDrG27YBJUVboOIILfFSijh0--h3Jj51DLqlpa601L1vqdAuXhxmu8P-jfRaC_8PZN2SDw</recordid><startdate>201306</startdate><enddate>201306</enddate><creator>Versporten, Ann</creator><creator>Sharland, Mike</creator><creator>Bielicki, Julia</creator><creator>Drapier, Nico</creator><creator>Vankerckhoven, Vanessa</creator><creator>Goossens, Herman</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201306</creationdate><title>The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide</title><author>Versporten, Ann ; Sharland, Mike ; Bielicki, Julia ; Drapier, Nico ; Vankerckhoven, Vanessa ; Goossens, Herman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c171t-53478a10f4136b14f0ee982b8eb88dff7065bf759f8b721446d6e05182ac28eb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Child</topic><topic>Drug Prescriptions - statistics &amp; numerical data</topic><topic>Drug Resistance, Bacterial</topic><topic>Drug Utilization - statistics &amp; numerical data</topic><topic>Electronic Data Processing</topic><topic>Europe</topic><topic>Health Services Research - methods</topic><topic>Health Services Research - standards</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Internet</topic><topic>Public Health Administration - methods</topic><topic>Public Health Administration - standards</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Versporten, Ann</creatorcontrib><creatorcontrib>Sharland, Mike</creatorcontrib><creatorcontrib>Bielicki, Julia</creatorcontrib><creatorcontrib>Drapier, Nico</creatorcontrib><creatorcontrib>Vankerckhoven, Vanessa</creatorcontrib><creatorcontrib>Goossens, Herman</creatorcontrib><creatorcontrib>ARPEC Project Group Members</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Pediatric infectious disease journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Versporten, Ann</au><au>Sharland, Mike</au><au>Bielicki, Julia</au><au>Drapier, Nico</au><au>Vankerckhoven, Vanessa</au><au>Goossens, Herman</au><aucorp>ARPEC Project Group Members</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide</atitle><jtitle>The Pediatric infectious disease journal</jtitle><addtitle>Pediatr Infect Dis J</addtitle><date>2013-06</date><risdate>2013</risdate><volume>32</volume><issue>6</issue><spage>e242</spage><epage>e253</epage><pages>e242-e253</pages><issn>0891-3668</issn><eissn>1532-0987</eissn><abstract>The neonatal and pediatric antimicrobial point prevalence survey (PPS) of the Antibiotic Resistance and Prescribing in European Children project (http://www.arpecproject.eu/) aims to standardize a method for surveillance of antimicrobial use in children and neonates admitted to the hospital within Europe. This article describes the audit criteria used and reports overall country-specific proportions of antimicrobial use. An analytical review presents methodologies on antimicrobial use. A 1-day PPS on antimicrobial use in hospitalized children was organized in September 2011, using a previously validated and standardized method. The survey included all inpatient pediatric and neonatal beds and identified all children receiving an antimicrobial treatment on the day of survey. Mandatory data were age, gender, (birth) weight, underlying diagnosis, antimicrobial agent, dose and indication for treatment. Data were entered through a web-based system for data-entry and reporting, based on the WebPPS program developed for the European Surveillance of Antimicrobial Consumption project. There were 2760 and 1565 pediatric versus 1154 and 589 neonatal inpatients reported among 50 European (n = 14 countries) and 23 non-European hospitals (n = 9 countries), respectively. Overall, antibiotic pediatric and neonatal use was significantly higher in non-European (43.8%; 95% confidence interval [CI]: 41.3-46.3% and 39.4%; 95% CI: 35.5-43.4%) compared with that in European hospitals (35.4; 95% CI: 33.6-37.2% and 21.8%; 95% CI: 19.4-24.2%). Proportions of antibiotic use were highest in hematology/oncology wards (61.3%; 95% CI: 56.2-66.4%) and pediatric intensive care units (55.8%; 95% CI: 50.3-61.3%). An Antibiotic Resistance and Prescribing in European Children standardized web-based method for a 1-day PPS was successfully developed and conducted in 73 hospitals worldwide. It offers a simple, feasible and sustainable way of data collection that can be used globally.</abstract><cop>United States</cop><pmid>23838740</pmid><doi>10.1097/INF.0b013e318286c612</doi></addata></record>
fulltext fulltext
identifier ISSN: 0891-3668
ispartof The Pediatric infectious disease journal, 2013-06, Vol.32 (6), p.e242-e253
issn 0891-3668
1532-0987
language eng
recordid cdi_proquest_miscellaneous_1399507649
source MEDLINE; Journals@Ovid Complete
subjects Anti-Bacterial Agents - therapeutic use
Child
Drug Prescriptions - statistics & numerical data
Drug Resistance, Bacterial
Drug Utilization - statistics & numerical data
Electronic Data Processing
Europe
Health Services Research - methods
Health Services Research - standards
Hospitals
Humans
Internet
Public Health Administration - methods
Public Health Administration - standards
title The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T01%3A47%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20antibiotic%20resistance%20and%20prescribing%20in%20European%20Children%20project:%20a%20neonatal%20and%20pediatric%20antimicrobial%20web-based%20point%20prevalence%20survey%20in%2073%20hospitals%20worldwide&rft.jtitle=The%20Pediatric%20infectious%20disease%20journal&rft.au=Versporten,%20Ann&rft.aucorp=ARPEC%20Project%20Group%20Members&rft.date=2013-06&rft.volume=32&rft.issue=6&rft.spage=e242&rft.epage=e253&rft.pages=e242-e253&rft.issn=0891-3668&rft.eissn=1532-0987&rft_id=info:doi/10.1097/INF.0b013e318286c612&rft_dat=%3Cproquest_cross%3E1399507649%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1399507649&rft_id=info:pmid/23838740&rfr_iscdi=true